Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00820495 · ClinicalTrials.gov registry record · Phase 2
Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users
A Phase 2 study of Tobacco Use Disorder, sponsored by Oregon Research Institute.
- Completed
- Registry status
- Phase 2
- Development phase
- 1,683
- Enrollment target
- 2
- Study locations
NCT00820495: Completed Phase 2 study of Tobacco Use Disorder, sponsored by Oregon Research Institute.
NCT00820495 is a Phase 2 study of Tobacco Use Disorder that has completed, run by Oregon Research Institute. The registered enrollment target is 1,683 participants, above the 215-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (683% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00820495, a Phase 2 study of Tobacco Use Disorder, has completed, sponsored by Oregon Research Institute.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,683 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this record is to test whether (a) participants who receive a Web-based smokeless tobacco cessation intervention will be more likely to be abstinent than participants who do not receive this intervention, and (b) whether participants who receive a telephone quitline intervention will be more likely to be abstinent than participants who are not in a quitline intervention.
Conditions Studied
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Web + Phone
- BEHAVIORAL Web Only
- BEHAVIORAL Phone Only
Study Locations (2)
California
- University of California, San Diego - San Diego
Oregon
- Oregon Research Institute - Eugene
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,683 participants |
| Start Date | 2009-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
What the finished NCT00820495 record still lists
NCT00820495 is an interventional study that assigns participants to a tested intervention. Its 1,683 participants enrollment target places it among the larger protocols in the corpus, above the 215-participant average among 70 other Tobacco Use Disorder trials with a reported enrollment target (683% higher).
The record links to 1 condition, with Tobacco Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.
NCT00820495 reports a single indexed study location in California, Oregon.
Frequently Asked Questions
What is clinical trial NCT00820495 about?
NCT00820495 is a clinical study titled "Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users". The purpose of this record is to test whether (a) participants who receive a Web-based smokeless tobacco cessation intervention will be more likely to be abstinent than participants who do not receive this intervention, and (b) whether participants who receive a telephone quitline intervention will ...
What is the current status of trial NCT00820495?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,683 participants. The study started on 2009-05. Estimated completion is 2012-05.
What conditions does trial NCT00820495 study?
This clinical trial studies the following conditions: Tobacco Use Disorder.
What interventions are being tested in trial NCT00820495?
The interventions under investigation include: Usual Care (BEHAVIORAL), Web + Phone (BEHAVIORAL), Web Only (BEHAVIORAL), Phone Only (BEHAVIORAL).
Who is sponsoring clinical trial NCT00820495?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00820495 being conducted?
This trial has 2 study locations across California, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00820495's enrollment target sits among peer trials
1,683 2nd of 70 the highest of 70 other Tobacco Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
RECRUITING · Phase 2
-
Examining the Effects of Cytisinicline on Neural Substrates of Cigarette Cue-reactivity
RECRUITING · Phase 2
-
Cannabidiol for Reducing Cigarette Use
RECRUITING · Phase 2
-
An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction
RECRUITING · Phase 2
-
Neuroimaging Correlates and Feasibility of Transcranial Magnetic Stimulation (TMS) to Improve Smoking Cessation Outcomes in Veterans With Comorbid PTSD
RECRUITING · Phase 2
-
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06376565 · 1,680 participants · NA
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
- NCT04852887 · 1,670 participants · Phase 3
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
- NCT04321200 · 1,700 participants
PANDA Gym: Automated Assessment of Neurodevelopment in Infants at Risk for Motor Disability
- NCT06238622 · 1,700 participants · Phase 3
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia